Journal article · 2008 · Open access
The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval
Clinical Pharmacology & Therapeutics, 84(2), 281–283 · Published 25 June 2008 · DOI 10.1038/clpt.2008.128
In brief
“The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval” is a 2008 journal article by LB Burke and 4 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 91 citations as of 22 November 2026. It is open access: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 91
- Most cited in
- 2019 (6)
- Field-weighted impact
- 12.95
- Authors
- 5
Abstract
Patient-reported outcome (PRO) measures provide an important perspective on how patients feel and function that cannot be adequately captured by clinical measures. A PRO is any report that comes directly from a patient about a health condition or its treatment without interpretation of the patient's response by a clinician or anyone else. Clinical Pharmacology & Therapeutics (2008); 84, 2, 281–283 doi:10.1038/clpt.2008.128
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Burke, L., Dl, K., Miskala, P., Papadopoulos, E., & Trentacosti, A. M. (2008). The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval. Clinical Pharmacology & Therapeutics, 84(2), 281–283. https://doi.org/10.1038/clpt.2008.128
MLA 9
Burke, LB, et al. “The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval.” Clinical Pharmacology & Therapeutics, vol. 84, no. 2, 2008, pp. 281–283. https://doi.org/10.1038/clpt.2008.128.
Chicago
Burke, LB, Kennedy Dl, PH Miskala, EJ Papadopoulos, and Ann Marie Trentacosti. 2008. “The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval.” Clinical Pharmacology & Therapeutics 84 (2): 281–283. https://doi.org/10.1038/clpt.2008.128.
Harvard
Burke, L. et al. (2008) ‘The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval’, Clinical Pharmacology & Therapeutics, 84(2), pp. 281–283. doi:10.1038/clpt.2008.128.
IEEE
L. Burke, K. Dl, P. Miskala, E. Papadopoulos, and A. M. Trentacosti, “The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval,” Clinical Pharmacology & Therapeutics, vol. 84, no. 2, pp. 281–283, 2008, doi: 10.1038/clpt.2008.128.
BibTeX
@article{burke2008patient,
title = {{The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval}},
author = {Burke, LB and Dl, Kennedy and Miskala, PH and Papadopoulos, EJ and Trentacosti, Ann Marie},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2008},
volume = {84},
number = {2},
pages = {281--283},
doi = {10.1038/clpt.2008.128},
url = {https://doi.org/10.1038/clpt.2008.128}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 2 | |
| 2018 | 4 | |
| 2019 | 6 | |
| 2020 | 5 | |
| 2021 | 5 | |
| 2022 | 4 | |
| 2023 | 1 | |
| 2024 | 3 | |
| 2025 | 5 | |
| 2026 | 1 |
Its field-weighted citation impact is 12.95: it has been cited 12.95 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- patient-reported outcome measures
- regulatory approval
- medical supplies
- drug approval
- patient perspectives
- health-related quality of life
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Burke, L., Dl, K., Miskala, P., Papadopoulos, E., & Trentacosti, A. M. (2008). The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval. Clinical Pharmacology & Therapeutics, 84(2), 281–283. https://doi.org/10.1038/clpt.2008.128
How many times has this paper been cited?
91 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
LB Burke, Kennedy Dl, PH Miskala, EJ Papadopoulos, Ann Marie Trentacosti.
What is the DOI of this paper?
10.1038/clpt.2008.128, permanently at https://doi.org/10.1038/clpt.2008.128. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.